These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10155250)

  • 1. Vascular applications of human gene therapy.
    Pickering JG; Takeshita S; Feldman L; Isner JM
    J Interv Cardiol; 1995 Aug; 8(4):373-6. PubMed ID: 10155250
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy and vascular disease.
    Kibbe M; Billiar T; Tzeng E
    Adv Pharmacol; 1999; 46():85-150. PubMed ID: 10332502
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy for vascular disease.
    Finkel T; Epstein SE
    FASEB J; 1995 Jul; 9(10):843-51. PubMed ID: 7615154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection efficiency and cytotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells.
    Kiefer K; Clement J; Garidel P; Peschka-Süss R
    Pharm Res; 2004 Jun; 21(6):1009-17. PubMed ID: 15212167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury.
    Takeshita S; Gal D; Leclerc G; Pickering JG; Riessen R; Weir L; Isner JM
    J Clin Invest; 1994 Feb; 93(2):652-61. PubMed ID: 8113401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for vascular diseases.
    Nabel EG
    Atherosclerosis; 1995 Dec; 118 Suppl():S51-6. PubMed ID: 8821465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon.
    Stephan D; San H; Yang ZY; Gordon D; Goelz S; Nabel GJ; Nabel EG
    Mol Med; 1997 Sep; 3(9):593-9. PubMed ID: 9323710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells.
    Kreuzer J; Denger S; Reifers F; Beisel C; Haack K; Gebert J; Kübler W
    Atherosclerosis; 1996 Jul; 124(1):49-60. PubMed ID: 8800493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-mediated gene transfer into human vascular smooth muscle cells.
    Pickering JG; Jekanowski J; Weir L; Takeshita S; Losordo DW; Isner JM
    Circulation; 1994 Jan; 89(1):13-21. PubMed ID: 8281638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo.
    Richter M; Iwata A; Nyhuis J; Nitta Y; Miller AD; Halbert CL; Allen MD
    Physiol Genomics; 2000 Apr; 2(3):117-27. PubMed ID: 11015590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smooth muscle cell polymeric transfection is an efficient alternative to traditional methods of experimental gene therapy.
    Arnold JD; Mountain DJ; Freeman MB; Kirkpatrick SS; Stevens SL; Goldman MH; Grandas OH
    J Surg Res; 2012 Sep; 177(1):178-84. PubMed ID: 22698428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lipophilic chloroquine analogues for a highly efficient gene transfer into gynecological tumors.
    Keil O; Bojar H; Prisack HB; Dall P
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2611-3. PubMed ID: 11551761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer and vascular disease.
    Nabel EG; Pompili VJ; Plautz GE; Nabel GJ
    Cardiovasc Res; 1994 Apr; 28(4):445-55. PubMed ID: 8181030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo.
    Armeanu S; Pelisek J; Krausz E; Fuchs A; Groth D; Curth R; Keil O; Quilici J; Rolland PH; Reszka R; Nikol S
    Mol Ther; 2000 Apr; 1(4):366-75. PubMed ID: 10933955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the surgeon scientist in gene therapy.
    Messina LM
    J Invest Surg; 1995; 8(5):335-6. PubMed ID: 8562528
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular gene transfer.
    Channon KM; Blazing MA; George SE
    Heart; 1996 Mar; 75(3):215-7. PubMed ID: 8800979
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects for intravascular gene therapy.
    Smith RC; Walsh K
    J Clin Apher; 1997; 12(3):140-5. PubMed ID: 9365867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for vascular diseases.
    Wu KK; Zoldhelyi P; Willerson JT; Xu XM; Loose-Mitchell DS; Wang LH
    Tex Heart Inst J; 1994; 21(1):98-103. PubMed ID: 8180517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.
    Mann MJ; Morishita R; Gibbons GH; von der Leyen HE; Dzau VJ
    Mol Cell Biochem; 1997 Jul; 172(1-2):3-12. PubMed ID: 9278227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.